News › Clinical Practice, Industry News, Patient Care

Candela Announces Health Canada Approval of New Gynecological Indications for CO2RE Laser Platform

June 18, 2020

Candela Corporation, a leading global aesthetic device company, has announced that Health Canada has approved the CO2RE laser, the world’s first fully integrated CO2 workstation, for the treatment of genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) in adult women.
The CO2RE laser, a single CO2 platform equipped with six treatment modes and multiple customized handpieces, is indicated for use in 10 medical specialties, including dermatology, aesthetics and gynecology. The CO2RE laser with Intima handpiece and module provides practitioners a simple and efficient gynecological solution for the treatment of the introitus, vaginal canal and external genitalia.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available